Clinical Trial Update: Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.

View source ↗

Summary

An ongoing clinical trial is evaluating recurrence risk factors in locally advanced breast cancer patients who underwent neoadjuvant chemotherapy, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Breast Cancer, Chemotherapy Effect | Status: RECRUITING